Lantz Financial LLC Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Lantz Financial LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 932 shares of the healthcare conglomerate’s stock after acquiring an additional 44 shares during the quarter. Lantz Financial LLC’s holdings in UnitedHealth Group were worth $461,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Bell Investment Advisors Inc raised its position in shares of UnitedHealth Group by 4.8% in the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after buying an additional 24 shares in the last quarter. Verdence Capital Advisors LLC boosted its position in shares of UnitedHealth Group by 2.1% during the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after acquiring an additional 342 shares during the last quarter. Bellecapital International Ltd. raised its stake in UnitedHealth Group by 1.4% in the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after purchasing an additional 193 shares in the last quarter. Rise Advisors LLC grew its stake in UnitedHealth Group by 326.0% in the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after buying an additional 163 shares in the last quarter. Finally, Gradient Investments LLC raised its position in shares of UnitedHealth Group by 6.3% during the 4th quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate’s stock valued at $44,370,000 after buying an additional 5,023 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on UNH. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. TD Cowen dropped their target price on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Truist Financial reiterated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Finally, Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $483.16 on Friday. The company has a market capitalization of $444.70 billion, a PE ratio of 29.53, a PEG ratio of 1.41 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The business has a fifty day moving average price of $497.01 and a 200-day moving average price of $504.26.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter last year, the firm earned $6.26 earnings per share. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, June 17th. This represents a $8.40 annualized dividend and a yield of 1.74%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.